Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
Akhil Santhosh, Consultant Medical Oncologist at Baby Memorial Hospitals, shared a post on X about a recent article by Claire N. Harrison et al., published in JCO Oncology Advances, adding:
“Efficacy and Safety Outcomes With Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia: Analysis of Data From the Phase III PERSIST-2 Study, JCO Oncology Advances.”
Title: Efficacy and Safety Outcomes With Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia: Analysis of Data From the Phase III PERSIST-2 Study
Authors: Claire N. Harrison, Prithviraj Bose, Ruben Mesa, Aaron T. Gerds, Stephen T. Oh, Marta Sobas, Valentín Garcia-Gutierrez, Christof Scheid, Alessandro Maria Vannucchi, Jean-Jacques Kiladjian, Vikas Gupta, Abdulraheem Yacoub, David Lavie, Purvi Suthar, Karisse Roman-Torres, Sarah A. Buckley, John Mascarenhas
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:06Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:04Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?
-
Sep 23, 2026, 00:02Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal